82 FR 34950 - Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities
FEDERAL RESERVE SYSTEM Federal Register Volume 82, Issue 143 (July 27, 2017)
Federal Register Volume 82, Issue 143 (July 27, 2017)
| Page Range | 34950-34950 | |
| FR Document | 2017-15872 |
[Federal Register Volume 82, Number 143 (Thursday, July 27, 2017)] [Notices] [Page 34950] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-15872] ----------------------------------------------------------------------- FEDERAL RESERVE SYSTEM Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y, (12 CFR part 225) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in Sec. 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than August 11, 2017. A. Federal Reserve Bank of New York (Ivan Hurwitz, Vice President) 33 Liberty Street, New York, New York 10045-0001. Comments can also be sent electronically to [email protected]: 1. China Merchants Group Limited, Hong Kong Special Administrative Region, the People's Republic of China; to engage de novo in extending credit and servicing loans and the leasing of personal property through CIMC Leasing USA Inc., Oakbrook Terrace, Illinois, pursuant to sections 225.28(b)(1) and 225.28(b)(3) of Regulation Y. Board of Governors of the Federal Reserve System, July 24, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017-15872 Filed 7-26-17; 8:45 am] BILLING CODE 6210-01-P
![34950 Federal Register / Vol. 82, No. 143 / Thursday, July 27, 2017 / Notices
Board of Governors of the Federal Reserve DEPARTMENT OF HEALTH AND literature by requesting information
System, July 24, 2017. HUMAN SERVICES from the public (e.g., details of studies
Yao-Chin Chao, conducted). We are looking for studies
Assistant Secretary of the Board. Agency for Healthcare Research and that report on Nonsurgical Treatments
[FR Doc. 2017–15871 Filed 7–26–17; 8:45 am] Quality for Urinary Incontinence in Adult
BILLING CODE 6210–01–P Women: A Systematic Review Update,
Supplemental Evidence and Data including those that describe adverse
Request on Nonsurgical Treatments events. The entire research protocol,
FEDERAL RESERVE SYSTEM for Urinary Incontinence in Adult including the key questions, is also
Women: A Systematic Review Update available online at: https://effective
Notice of Proposals To Engage in or AGENCY: Agency for Healthcare Research healthcare.ahrq.gov/index.cfm/search-
To Acquire Companies Engaged in and Quality (AHRQ), HHS. for-guides-reviews-and-reports/
Permissible Nonbanking Activities ?pageaction=display
ACTION: Request for Supplemental
product&productid=2479.
The companies listed in this notice Evidence and Data Submissions. This is to notify the public that the
have given notice under section 4 of the SUMMARY: The Agency for Healthcare EPC Program would find the following
Bank Holding Company Act (12 U.S.C. Research and Quality (AHRQ) is seeking information on Nonsurgical Treatments
1843) (BHC Act) and Regulation Y, (12 scientific information submissions from for Urinary Incontinence in Adult
CFR part 225) to engage de novo, or to the public. Scientific information is Women: A Systematic Review Update
acquire or control voting securities or being solicited to inform our review of helpful:
assets of a company, including the Nonsurgical Treatments for Urinary D A list of completed studies that
companies listed below, that engages Incontinence in Adult Women: A your organization has sponsored for this
either directly or through a subsidiary or Systematic Review Update, which is indication. In the list, please indicate
other company, in a nonbanking activity currently being conducted by the whether results are available on
that is listed in § 225.28 of Regulation Y AHRQ’s Evidence-based Practice ClinicalTrials.gov along with the
(12 CFR 225.28) or that the Board has Centers (EPC) Program. Access to ClinicalTrials.gov trial number.
determined by Order to be closely D For completed studies that do not
published and unpublished pertinent
related to banking and permissible for have results on ClinicalTrials.gov,
scientific information will improve the
bank holding companies. Unless please provide a summary, including
quality of this review.
otherwise noted, these activities will be the following elements: Study number,
DATES: Submission Deadline on or
conducted throughout the United States. study period, design, methodology,
before August 28, 2017. indication and diagnosis, proper use
Each notice is available for inspection ADDRESSES:
at the Federal Reserve Bank indicated. instructions, inclusion and exclusion
Email submissions: SEADS@epc- criteria, primary and secondary
The notice also will be available for src.org. outcomes, baseline characteristics,
inspection at the offices of the Board of Print submissions: Mailing Address: number of patients screened/eligible/
Governors. Interested persons may Portland VA Research Foundation, enrolled/lost to follow-up/withdrawn/
express their views in writing on the Scientific Resource Center, ATTN: analyzed, effectiveness/efficacy, and
question whether the proposal complies Scientific Information Packet safety results.
with the standards of section 4 of the Coordinator, P.O. Box 69539, Portland, D A list of ongoing studies that your
BHC Act. OR 97239. organization has sponsored for this
Unless otherwise noted, comments Shipping Address (FedEx, UPS, etc.): indication. In the list, please provide the
regarding the applications must be Portland VA Research Foundation, ClinicalTrials.gov trial number or, if the
received at the Reserve Bank indicated Scientific Resource Center, ATTN: trial is not registered, the protocol for
or the offices of the Board of Governors Scientific Information Packet the study including a study number, the
not later than August 11, 2017. Coordinator, 3710 SW., U.S. Veterans study period, design, methodology,
A. Federal Reserve Bank of New York Hospital Road, Mail Code: R&D 71, indication and diagnosis, proper use
(Ivan Hurwitz, Vice President) 33 Portland, OR 97239. instructions, inclusion and exclusion
Liberty Street, New York, New York FOR FURTHER INFORMATION CONTACT: criteria, and primary and secondary
10045–0001. Comments can also be sent Ryan McKenna, Telephone: 503–220– outcomes.
electronically to 8262 ext. 51723 or Email: SEADS@epc- D Description of whether the above
Comments.applications@ny.frb.org: src.org. studies constitute ALL Phase II and
1. China Merchants Group Limited, SUPPLEMENTARY INFORMATION: The above clinical trials sponsored by your
Hong Kong Special Administrative Agency for Healthcare Research and organization for this indication and an
Region, the People’s Republic of China; Quality has commissioned the index outlining the relevant information
to engage de novo in extending credit Evidence-based Practice Centers (EPC) in each submitted file.
and servicing loans and the leasing of Program to complete a review of the Your contribution will be very
personal property through CIMC evidence for Nonsurgical Treatments for beneficial to the EPC Program. Materials
Leasing USA Inc., Oakbrook Terrace, Urinary Incontinence in Adult Women: submitted must be publicly available or
Illinois, pursuant to sections A Systematic Review Update. AHRQ is able to be made public. Materials that
225.28(b)(1) and 225.28(b)(3) of conducting this systematic review are considered confidential; marketing
pursuant to Section 902(a) of the Public materials; study types not included in
mstockstill on DSK30JT082PROD with NOTICES
Regulation Y.
Health Service Act, 42 U.S.C. 299a(a). the review; or information on
Board of Governors of the Federal Reserve The EPC Program is dedicated to indications not included in the review
System, July 24, 2017. identifying as many studies as possible cannot be used by the EPC Program.
Yao-Chin Chao, that are relevant to the questions for This is a voluntary request for
Assistant Secretary of the Board. each of its reviews. In order to do so, we information, and all costs for complying
[FR Doc. 2017–15872 Filed 7–26–17; 8:45 am] are supplementing the usual manual with this request must be borne by the
BILLING CODE 6210–01–P and electronic database searches of the submitter.
VerDate Sep<11>2014 19:17 Jul 26, 2017 Jkt 241001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\27JYN1.SGM 27JYN1](https://thefederalregister.org/doc/82_FR_35093/page/1.svg)
Document Created: 2017-07-27 02:07:18
Document Modified: 2017-07-27 02:07:18
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 82 FR 34950 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR